SCHEMBL5440971

SCHEMBL5440971

COc1sc2ccccc2c1CCl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.38
TDP1 Q9NUW8 2/20 0.38
MAPT P10636 6/20 0.38
ALDH1A1 P00352 5/20 0.38
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
KDM4E B2RXH2 3/20 0.38
HSD17B10 Q99714 3/20 0.37
CYP1A2 P05177 2/20 0.37
TSHR P16473 2/20 0.37
NFKB1 P19838 2/20 0.37
CYP2D6 P10635 1/20 0.37
FTO Q9C0B1 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
MAPK1 P28482 4/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 3/20 0.36
ALOX15 P16050 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477083 0.77 CYP1A2 (0.51) GPR3L3MBTL1TDP1MAPTALDH1A1
SCHEMBL9272529 0.77 PTPN2 (0.43) L3MBTL1TDP1MAPTALDH1A1KDM4E
SCHEMBL13713800 0.73 GPR3 (0.46) GPR3L3MBTL1TDP1MAPTALDH1A1
SCHEMBL7769015 0.73 ALDH1A1 (0.50) GPR3L3MBTL1TDP1MAPTALDH1A1
SCHEMBL31536923 0.72 GPR3 (0.44) GPR3L3MBTL1TDP1MAPTALDH1A1
SCHEMBL10566672 0.69 LOXL2 (0.46) GPR3HSD17B10CYP1A2TSHRNFKB1
SCHEMBL5986359 0.67 GPR3 (0.39) GPR3L3MBTL1TDP1ALDH1A1KDM4E
SCHEMBL6151703 0.67 LMNA (0.53) L3MBTL1TDP1MAPTALDH1A1NPC1
SCHEMBL20932951 0.66 LTA4H (0.50) L3MBTL1TDP1MAPTALDH1A1NPC1
SCHEMBL15450945 0.66 CYP1A2 (0.51) GPR3L3MBTL1TDP1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 GPR3 932/4885L3MBTL1 4316/4885TDP1 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.